INTRODUCTION:
Ayurveda is an ancient system of medicine
having eternal principles which are equally applicable even in current period. Although
newer and newer diseases are being observed in the society due to drastically
changed environmental factors, food and behavioural regimens, Ayurveda with its
firm principles can deal with these new diseases using the system of diagnosis
and treatment for anukta vyadhi mentioned in classical texts. Sitapitta
is one of such diseases which is not mentioned in brhattrayi texts, but
laghutrayi texts tried to explore its details as probably it may observed as
separate disease in later time. Sitapitta is the tridosaja vyadhi
in which as a result of exposure to cold air, kapha and vata dosa gets provoked
and spread over the skin and internal body along with pitta
casing the sotha resembling with varati dasta sotha, excessive kandu, toda,
cchardi, jwara and vidaha. Madhava and
later authors opined that Sitapitta occurs due to vata predominant condition.
Hetu, linga and ausadha are mentioned as
triskandha of Ayurveda presenting three aspects applicable to entire
concepts mentioned therein. Application
of the principle of one disease in another disease, can be thought in these
three aspects. Sitapitta which is having causative factor as cold
air exposure, can be treated with the principle of abhisangaja jwara wherein
the disease is said to be occurred due to visa-vriksa-anila-sparsa i.e
exposure to the air blowing through poisonous tree. In
current scenario, the air pollution causing due to continuous addition of
poisonous air particles by the industrial set ups, is big issue at least in the
metro cities. Exposure to such air can also be considered under the concept
mentioned in abhisangaja jwara. On the basis of partially similar hetu
i.e. exposure to air, principle of abhisangaja jwara can be utilized in
treating Sitapitta. Abhisangaja jwara which is caused due to vata-pitta
samsarga as per the abhisangajah punarvata-pittabhyam
and Sitapitta which is caused due to vata-pitta as per the
quotations vatadhikam Sitapitta and pittena saha sambhuya, can be kept
under same umbrella of hetu due to similar samavayi karana (vata-pitta)
and nimitta karana (anila samsparsa). The principle of abhisangaja jwara
‘cikitsaya visaghnyaiva sa samam labhate narah’ having advice of usage of visaghna
treatment can be applied to Sitapitta.
Bhesaja catuska of caraka-samhita
encloses mahakasaya having wide clinical application. Visaghna mahakasaya
which consists of 10 drugs can be chosen as best choice for visaghna treatment due to its wide
application Hence hypothesis is presented on the basis of these concepts in
which principle of jvara is thought to be well applicable in Sitapitta.
The disease Sitapitta is often co
related with a condition called Urticaria. Urticaria is an allergic reaction of
the skin to a variety of exogenous and endogenous antigens. It is a common
disease nowadays, characterized by pale red rashes and severe itching caused by
an allergic reaction. Vascular dilatation, the resultant dermal oedema and pruritus
are due to the releases of histamine and other mediators from mast cells.
Although, any disease mentioned in Ayurveda cannot be completely compared in
all aspects with the parallel modern disease, for the purpose to statistical
analysis on the basis of objective parameters, the pathological investigations
like IgE, DLC, ESR, are planned to be incorporated in the study.
Need of
study:
Sitapitta is commonly observed heath problem among
society. When the modern counterpart of Sitapitta i.e. urticaria, is compared for knowing the prevalence of the
disease, it is observed that approximately 15 to 20% of the general population are
found to get suffered from urticaria at
least once during their lifetime. Although persons of any age may experience
urticaria and/or angioedema. This disease occurs most frequently after
adolescence, with the highest incidence in young adults. The exact incidence
and prevalence of chronic condition of this disease are not known, although it
occurs in at least 0.1% and possibly up to 3% of the population. Though the disease is not life threatening,
it makes patient worried, due to its appearance and severe pruritus. The modern
medicine provides temporary symptomatic relief and patient has to take
medicines for long time, which may be having some unwanted side effects. So a
complete relief from the condition without its recurrence is still a question
which could be sought out by Ayurveda.
When classical texts of Ayurveda are reviewed, Sitapitta is not mentioned in brhata trayi.
so it is important to find the applicability of the principles of brhata
trayi in diseases mentioned in other text books also.
Since the role of polluted air and other
poisonous articles in this condition the use of Visaghna mahakasaya Ghanavati
should be better understood with respect to Sitapitta .
Haridrakhanda is the medicine of
choice in current practice as treatment of Sitapitta . Since it involves sugar content it is not that
much suitable for the patients who are having condition of Diabetes mellitus.
Since Visaghna mahakasaya Ghanavati
do not possess that much of sugar content it can be safely given to patients of
Sitapitta
who are also having an association of diabetes.
No
study is yet carried out in showing the results of visaghna mahakasaya
in Sitapitta. Considering all
above points the current study is highly needed.
Research
question:
Is there any difference
between the efficacy of Visaghna - mahakasaya
Ghanavati and Haridrakhanda in the context of the principle of Cikitsaya
Visaghnyaiva sa samam labhate narah in the management of Sitapitta ?
Hypothesis:
Null hypothesis
There is no difference between the efficacy of Visaghna -mahakasaya -ghanavati and Haridrakhanda
in the management of Sitapitta in the context of the principle of ‘Cikitsaya
Visaghnyaiva sa samam labhate narah
Alternate hypothesis
There is a difference between the efficacy of Visaghna
- mahakasaya -Ghanavati and Haridrakhand in the management of Sitapitta in
the context of the principle of ‘Cikitsaya Visaghnyaiva sa samam labhate
narah
Aim
To study and compare the efficacy of Visaghna - mahakasaya -Ghanavati and Haridrakhand
in patients of Sitapitta in
the context of the principle of Cikitsaya Visaghnyaiva sa samam labhate narah
Objectives:
To evaluate the effect of Visaghna - mahakasaya -Ghanavati in the management
of Sitapitta .
To compare the efficacy of Visaghna - mahakasaya -Ghanavati and Haridrakhand
in the management of Sitapitta
1) MATERIAL AND METHODS:
Literary references related
to the study will be collected from the texts of Carakasamhita, Madhava
Nidana, Cakradatta, Bhavaprakasa, Bhaisajyaratnavali, and Yogaratnakara
their commentaries. Relevant modern literature, research journals and online
sources will be accordingly referred and analysed.
A)
Selection of
cases-
Population-
patients of Sitapitta visiting NIA (OPD & IPD)
Sample
size –50 ( 25 each group)
Diagnostic
Criteria – Sign and symptoms of Sitapitta
as per classical texts.
Inclusion
Criteria
Patients
between the age group 18-60 years of age
Patients
of either gender
The
patients having classical signs and symptoms of Sitapitta .
Patients
willing to participate in the clinical trial
Exclusion
Criteria-
Patient
with long term history of steroid and cytotoxic treatment
Pregnant
and lactating women
Patients
having concomitant illness like uncontrolled Hypertension, uncontrolled
Diabetes mellitus, HIV, Malignancy, etc.
Anaphylaxis,
Angioedema of the lips, tongue or larynx etc.
Withdrawal
criteria:
The participant who
develops any serious condition or any serious adverse effect (Necessitating
hospitalization). Patient wants to
withdraw from the clinical trial due to
any reason
Selection
of drug;-
Trial drugs:- Visaghna - mahakasaya - Ghanavati
|
No
|
Ingredients
|
Botanical
name
|
Used part
|
Quantity
|
|
1.
|
Haridra
|
Curcuma longa Linn.
|
Kanda
|
1
part
|
|
2.
|
Manjistha
|
Rubia
cordifolia Linn.
|
Mool
|
1
part
|
|
3.
|
Rasna
|
Pluchea lanceolata C.B
Clarke
|
Patra
|
1
part
|
|
4.
|
Shukshaila
(Ela)
|
Elettaria cardamom Maton
|
Beej
|
1
part
|
|
5.
|
Palindi(kri
shnasariva)
|
Cryptolepis buchanana Roem
& Schult
|
Mool
|
1
part
|
|
6.
|
Candana(ra
ktacandan)
|
Pterocarpus
santalinus Linn.
|
Kandsaar
|
1
part
|
|
7.
|
Kataka
|
Strychnos
potatorum Linn.
|
Beej
|
1
part
|
|
8.
|
Sirisa
|
Albizzia
lebbeck Benth
|
Twak,Beej,P
atra,Pushpa
|
1
part
|
|
9.
|
Sindhuvara
|
Vitex
negundo Linn
|
Patra,Mool,
Beej
|
1
part
|
|
10.
|
Slesmataka
|
Cordia dichotoma Forst.
F.
|
Phala
|
1
part
|
Compare drug: -Haridrakhanda:
|
NO
|
NAME
|
BOTANICAL NAME
|
USEFUL PART
|
QUANTITY
|
|
1.
|
Haridra
|
Curcuma
longa Linn
|
Kanda
|
1
kudava
|
|
2.
|
Trivrta
|
Operculina turpethum Linn
|
Moola
twak
|
4
pala
|
|
3.
|
Abhaya
|
Terminalia
chebula Retz
|
Phala
|
4 pala
|
|
4
|
Sita
|
|
|
Sa ardha prastha dwayam
|
|
5.
|
Darvi
|
Berberis aristate DC
|
Moola, Kanda,Phala
|
1 Kola
|
|
6.
|
Musta
|
Cyperus
rotundus Linn
|
Kanda
|
1Kola
|
|
7.
|
Ajavaina
|
Trachyspermum ammi Linn
|
Phala
|
1Kola
|
|
8.
|
Ajamoda
|
Carum roxburghianum DC Craib
|
Phala
|
1Kola
|
|
9.
|
Citraka
|
Plumbago
zylenica Linn
|
Moola
twak
|
1Kola
|
|
10
|
Katu
rohini
|
Piccorhiza
kurroa Royle ex Benth
|
Moola
|
1Kola
|
|
11
|
Ajaji(jirak)
|
Cuminum cyminum Linn
|
Beeja
|
1Kola
|
|
12
|
Pippali
|
Piper longum Linn
|
Phala
|
1Kola
|
|
13
|
Sunthi
|
Zingiber
officinale Rosc
|
Kanda
|
1 Kola
|
|
14
|
Dalacini
|
Cinnamomnm zeylanicum Breyn
|
Twaka
|
1
kola
|
|
15
|
Tejapatra
|
Cinnamomnm tamala Nees & Eberm
|
Patra
|
1
kola
|
|
16
|
Ela
|
Elettari acardamomum Maton
|
Beej
|
1
kola
|
|
17
|
Vidanga
|
Embelia ribes Burm
|
Phal
|
1
kola
|
|
18
|
Amrta
|
Tinospora cardifolia Willd
|
Kanda
|
1
kola
|
|
19
|
Vasa
|
Adhatoda vasica Nees
|
Patra,Pushpa,Moola
|
1
kola
|
|
20
|
Kustha
|
Saussurea lappa C.B
Clarke
|
Moola
|
1
kola
|
|
21
|
Amalaki
|
Emblica
officinalis Gaertn
|
Phala
|
1kola
|
|
22
|
Haritaki
|
Terminalia
chebula Retz
|
Phala
|
1
kola
|
|
23
|
Vibhitaki
|
Terminalia bellirica Roxb.
|
Phala
|
1
kola
|
|
24
|
Cavya
|
Piper retrofractum Vahl
|
Phala,Moola
|
1
kola
|
|
25
|
Dhanyaka
|
Coriandrum sativum Linn
|
Phala
|
1
kola
|
|
26
|
Mrutta
lauha
|
|
Bhasma
|
1kola
|
|
27
|
Mrutta
abhra
|
|
Bhasma
|
1kola
|
Prepaeration of drug
The trial drugs will be prepared in GMP
certified NIA pharmacy Jaipur, by classical methods.
Visaghna
- mahakasaya -Ghanavati:-
The kvatha of Visaghna - mahakasaya
drugs with 16 parts of water will be prepared. Then it will be heated till the
formation of Ghana and after that vati will be prepared.
METHODOLOGY
Type of study – Comparative Randomized
Clinical Trial (open, randomized, comparative, prospective)
Intervention- Patients of Sitapitta –divided into two groups
GROUP A- 25 Patients Haridrakhand -6 gm (divided dose) twice
a day for 30 days. ,Anupana lukewarmwater,
Morning and Evening upto half an hour after completion of food (adhobhakta)
GROUP B- 25 Patients- Visaghna - mahakasaya -Ghanavati 4 gm (divided dose)
twice a day for 30 days. Anupana-water,Morning
and Evening upto half an hour after completion of food(adhobhakta)
Follow up- every 15 days. Assessment of patients based on
criteria will be done before and after the trial period
Assesment
criteria:
All the patients will be assessed for relief in classical signs and
symptoms and objective parameters after the completion of trial. To give
objectivity to subjective classical signs and symptoms grading/scoring system
will be adopted which is as follows-
Subjective parameters :
Varati
Damsta samsthana Sotha
Kandu
Bahula
Toda
Bahula
Chardi
Jvara
Vidaha
Scoring criteria:
Urticaria Activity Score
|
Sr. no.
|
Wheals or hives
|
Grade
|
|
1
|
None
|
0
|
|
2
|
Mild (<20
wheals/24h)
|
1
|
|
3
|
Moderate (21-50 wheals/24h)
|
2
|
|
4
|
Intense or severe (>50 wheals/24h or large confluent
areas of wheals)
|
3
|
Severity of itching
|
Sr.no
|
Itching
|
Grade
|
|
1
|
No Itching
|
0
|
|
2
|
Mild/Occasional itching
|
1
|
|
3
|
Moderate frequent itching
|
2
|
|
4
|
Severe frequent itching
|
3
|
|
5
|
Very severe itching, which disturb sleep and other routine
activity
|
4
|
|
URTICARIA CONTROL TEST 1.
How much have you suffered from the physical symptom of the urticarial(itch,
hives(welts), and swelling) in the last four weeks?
|
|
|
Very much 0
|
Much 1
|
Somewhat 2
|
A little 3
|
Not at all 4
|
|
2. How much was your quality of life affected by the urticaria
in the last four weeks?
|
|
|
Very much 0
|
Much 1
|
Somewhat 2
|
A little 3
|
Not at all 4
|
|
3. How often was the treatment for your urticaria in the last
four weeks not enough to control your urticaria symptoms?
|
|
|
Very often 0
|
Often 1
|
Sometimes 2
|
Seldom 3
|
Not at all 4
|
|
4. Overall how well have you had your urticarial under
control in the last four weeks?
|
|
|
Not at all 0
|
A little 1
|
Somewhat 2
|
Well 3
|
Very well 4
|
|
TOTAL SCORE:
|
|
A score of 16 indicates complete disease
control . A score of < 12 on the UCT identifies patients with poorly
controlled chronic urticaria (CU) , and a score of > 12 identifies those with
well-controlled symptoms. An improvement in 3 points is a minimal response ,
and an improvement of > 6 points is a marked response.
AYURVEDA SCORING PATTERN
Varati Damsta samsthana
Sotha (Mandalotpatti)
|
Parameters
|
Score
|
|
Not present
|
0
|
|
Up to 25% skin involvement
|
1
|
|
25-50% skin involvement
|
2
|
|
51-75% skin involvement
|
3
|
|
More than 75% skin
involvement
|
4
|
Kandu
|
Parameters
|
Score
|
|
No
|
0
|
|
Mild
|
1
|
|
Moderate
|
2
|
|
Severe
|
3
|
|
Unbearable and disturbing
routine
|
4
|
Toda :
|
Parameters
|
Score
|
|
No
|
0
|
|
Mild
|
1
|
|
Moderate
|
2
|
|
Severe
|
3
|
|
Unbearable and disturbing
routine
|
4
|
Associated
symptoms like chardi, jvara, vidaha,
|
Parameters
|
Score
|
|
No
|
0
|
|
Mild
|
1
|
|
Moderate
|
2
|
|
Severe
|
3
|
|
Unbearable
|
4
|
Frequency of attack
|
Parameters
|
Score
|
|
No
|
0
|
|
Once in 4-5 days
|
1
|
|
Once in alternate day
|
2
|
|
Once in daily
|
3
|
|
Twice daily
|
4
|
Objective:
IgE, DLC, ESR
STATISTICAL
ANALYSIS
Subjective
parameters
Wilcoxon’s
paired rank test
Mann
whitney U test
Objective parameters
Paired
‘t’ test
Unpaired
‘t’ test
2)
OUTCOMES-
Primary Outcome-Change in classical symptoms of sheetpitta
such as Varati damsta samsthana sotha, Kandu bahula, Toda bahula, Chardi, Jvara,
Vidaha
Secondary Outcome-Change in IgE, DLC ,ESR
PROPOSED CONTENT OF
DISSERTATION
The work will be presented in the form of a
thesis with following contents-
Benediction
Acknowledgement
Introduction
Review of literature
I.
Ayurveda review of Sitapitta
II.
Modern review of Urticaria
III.
Drug review
Clinical Study
Observations and results
Discussion and summary
Conclusion
Bibliography
Appendix
BIBLIOGRAPHY
Carakasamhita with Ayurvedadipika
commentary, edited by Vd. J yadavji
Trikamji
acarya Published by Chaukhambha Surbharti prakashan, Varanasi, Reprient edition
2019. cha chi. 3/117
Carakasamhita with Ayurvedadipika commentary, edited by Vd. J yadavji
Trikamji
acarya Published by Chaukhambha Surbharti prakashan, Varanasi, Reprient edition
2019. cha chi. 3/118
Carakasamhita with Ayurvedadipika commentary, edited by Vd. J yadavji
Trikamji
acarya Published by Chaukhambha Surbharti prakashan, Varanasi, Reprient edition
2019. cha sutra. 4/ 11
Carakasamhita with Ayurvedadipika commentary, edited by Vd. J yadavji
Trikamji
acarya Published by Chaukhambha Surbharti prakashan, Varanasi, Reprient edition
2019 cha ni 1/30
Sri
Madhavkara, Madhav Nidana Vol 2, Sitapitta
udardakothnidanam, 50/1, Vidyotini hindi commentary by Sudarshan
Shastri, Chaukhambha Prakashan, Varanasi, 2014;
Sri
Madhavkara, Madhav Nidana Vol 2, Sitapitta
udardakothnidanam, 50/3-5, Vidyotini hindi commentary by Sudarshan
Shastri, Chaukhambha Prakashan, Varanasi, 2014;
Bhaishajyaratnavali
of GovindaDasji, Sitapittaudardakota cikitsa 55/18-22, Varanasi, Chaukhamba Sanskrit
Sansthan, Volume 3, Print 2009
Davidson S (2006).Davidsons
principles and practice of medicine 20th edition, USA Elseviers Health Science.
Ahmad W.
Bilal, Ahmad S Mir (201) Research Methodology And Medical Statics for Ayurveda
Scholar, Jaipur Ayurved Sanskrit Hindi Pustak Bhandar.
DravyagunaVijnana
vol-2edition 2020 by PV Sharma
API Part I
Volume 1,2,3,4,5,6
Diagnosis
and management of urticaria in Indian settings: Skin allergy research society’s
guideline-2022 Godse K, Patil A, De A, Sharma N, Rajagopalan M, Shah B,
Tahiliani S, Girdhar M, Zawar V, Sangolli P, Shankar DK, Dhar S - Indian J
Dermatol (e-ijd.org)
|